Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Poisoning by salicylates, intentional self-harm (ICD-10 Code: T39.092)
Summary
This condition represents intentional self-harm resulting from exposure to salicylates, a class of compounds including aspirin and related derivatives. Salicylates are commonly used for pain relief, anti-inflammatory effects, and cardiovascular protection, but intentional overdose can lead to systemic toxicity. The severity depends on the dose ingested and individual factors such as age and metabolic capacity.
Causes
Intentional salicylate poisoning typically occurs due to deliberate overdose, often as a result of suicidal intent. It may involve consuming excessive amounts of salicylate-containing medications, either alone or in combination with other substances. The motivation is self-inflicted harm, and the outcome depends on the dose, timing of intervention, and individual health status.
Risk Factors
- Mental health conditions: Depression, anxiety, or other psychiatric disorders may increase risk.
- Prior self-harm history: Individuals with a history of suicidal behavior are at higher risk.
- Access to medications: Unrestricted access to salicylate-containing products can facilitate overdose.
- Substance use: Concurrent use of alcohol or other drugs may influence intent or dosing.
- Social isolation: Lack of support or supervision may contribute to self-harm behaviors.
Symptoms
- Nausea, vomiting, and abdominal pain.
- Tinnitus (ringing in the ears) and hearing loss.
- Hyperventilation, respiratory alkalosis, or metabolic acidosis.
- Dizziness, confusion, or altered mental status.
- Seizures, coma, or cardiovascular instability in severe cases.
Diagnosis
Diagnosis involves clinical evaluation, including a detailed history of the event and symptoms. Laboratory tests may include serum salicylate levels, electrolyte panels, and arterial blood gas analysis to assess acid-base status. Imaging or other studies may be performed to rule out complications. Documentation of intentional self-harm is critical for accurate coding.
Treatment Options
Treatment focuses on stabilizing the patient, reducing absorption, and managing symptoms. Interventions may include activated charcoal, intravenous fluids, and alkalinization of urine to enhance excretion. Severe cases may require intensive care, respiratory support, or dialysis. Psychiatric evaluation and support are essential for addressing underlying intent.
Prognosis and Follow-Up
Prognosis depends on the dose ingested, timeliness of treatment, and individual factors. Early intervention improves outcomes, but severe toxicity can lead to long-term complications or death. Follow-up care includes monitoring for recurrence, addressing mental health needs, and providing education on safe medication use.
Complications
- Gastrointestinal bleeding or perforation.
- Respiratory failure or acute lung injury.
- Renal failure or hepatic dysfunction.
- Neurological damage, including seizures or coma.
- Metabolic disturbances, such as severe acidosis.
Lifestyle & Prevention
- Secure storage of medications to prevent access.
- Education on proper dosing and risks of overdose.
- Mental health support and crisis intervention for at-risk individuals.
- Avoidance of self-medication with high-dose salicylates.
- Regular follow-up with healthcare providers for chronic conditions.
When to Seek Professional Help
Seek immediate medical attention if intentional overdose is suspected or if symptoms such as severe nausea, vomiting, confusion, or difficulty breathing occur. Prompt care is critical to minimize toxicity and address underlying intent.
Tips for Medical Coders
Document the intent (intentional self-harm) clearly in the medical record, as this determines the use of T39.092. Ensure the diagnosis aligns with clinical findings and history. Verify that the code is not used for accidental or undetermined intent, as these require different codes. Include details about the substance involved and the clinical course for accurate coding and reporting.
T39.092 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.